We’re using cookies to give you the best experience possible of Essity.com. Read more about the cookies we use and how to change your settings:

Essity B 316.2 (-2.8 SEK) on 21-Feb-2020 17:29

Select region

Global Site


Essity’s Medical Solutions product segment originates from the acquisition of BSN medical, a leading medical solutions company acquired on April 3, 2017. BSN medical develops, manufactures and sells products within wound care, compression therapy and orthopedics.

BSN medical is an innovative medical solutions company with well-known brands such as Leukoplast, Cutimed, JOBST, Delta and Actimove. Medical Solutions had sales in approximately 140 countries and production in eleven countries as well as approximately 6,000 employees, as of December 31, 2016. The largest markets in terms of sales in 2016 were Europe, North America and Asia Pacific. Distribution channels are mainly hospitals/specialists, pharmacies and sanitary shops. Essity’s operations within the product segment Medical Solutions has a sales organization consisting of approximately 1,650 employees.

Following the acquisition of BSN medical, Essity’s product segment Medical Solutions offer products and solutions within wound care, compression therapy and orthopedics. Essity’s acute wound care offering contains a broad range of products including surgical tapes, retention bandages, surgical/post-operation dressings and adhesive bandages/plaster, and advanced wound care, with products for treatment of difficult and complex wounds. Essity is the world’s fourth largest player within the product segment. Essity holds the leading market position within acute wound care in Europe and holds the number two position globally. Essity recently expanded its advanced wound care offering to include pump technology. Within compression therapy, Essity offers a broad range of phlebology products including compression stockings, medical compression garments, and lymphology products such as compression bandages, wraps, garments and pneumatic compression pumps. Essity holds the number four position globally within phlebology products and is the number one global provider of lymphology products. Within orthopedics, Essity offers a broad range of products within fracture management, including cast tape, splinting, casting accessories, physiotherapy, with products for support bandages and tapes, and orthopedics soft goods and braces, including support bandages and tapes. Essity holds the number one market position globally within both fracture management and physiotherapy.


Essity believes that the acquisition of BSN medical is an excellent strategic fit for Essity and supports Essity’s vision dedicated to improve well-being through leading hygiene and health solutions, two closely interlinked areas. BSN medical has leading market positions in several attractive medical product categories and provides a new growth platform with future industry consolidation opportunities. Essity’s incontinence business, with the global leading TENA brand, shares similar positive market characteristics, customer and sales channels with BSN medical, which provides opportunities for accelerated growth through cross-selling. BSN medical has a high cash conversion and an asset light business model.